Navigation Links
Role of estrogen in colon cancer prevention, treatment studied at UH
Date:10/21/2013

HOUSTON, Oct. 21, 2013 As the second leading cause of cancer-related deaths in the U.S., colon cancer affects both men and women and is expected to cause more than 50,000 deaths this year. University of Houston (UH) professor Cecilia Williams has been awarded a $1.56 million grant from the National Cancer Institute (NCI) to investigate the mechanistic basis for novel colon cancer prevention and therapy.

While a truly preventive or targeted therapy against colon cancer does not yet exist, estrogen has been shown to reduce incidence of this disease. Williams, an assistant professor with the UH Center for Nuclear Receptors and Cell Signaling (CNRCS), plans to provide a detailed understanding of the role and potential of the nuclear receptor estrogen receptor beta (ERbeta) in colon cancer prevention and treatment.

A large body of work has suggested that signals conveyed by estrogen can prevent or delay colon cancer development, but little is understood of the underlying mechanisms. Williams' lab offers unique models and data that can clarify how estrogen influences colon cancer development. Through this five-year project, the lab will investigate the mechanistic basis for novel colon cancer prevention and therapy using ERbeta to validate biomarkers and develop future therapy and prevention strategies.

"Our preliminary studies, performed with the help of graduate students Karin Edvardsson, Trang Vu and Philip Jonsson, have yielded positive results, and we look forward to expanding upon our research with this this NCI grant," Williams said. "Our goal is to increase opportunities for improved colon cancer prevention and therapies."

This work also involves experts within related fields, including Jonna Frasor at the University of Illinois at Chicago, who studies estrogen and inflammation in the breast; Dr. Christopher Garrett at the University of Texas M.D. Anderson Cancer Center, a colon cancer clinician; Preethi Gunaratne, a bioinformatics researcher and professor in the UH College of Natural Sciences and Mathematics; and UH CNRCS Director Dr. Jan-ke Gustafsson, who discovered ERbeta in the mid-1990s.

The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services. The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training.


'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Related medicine news :

1. BUSM researchers identify genetic markers for testosterone, estrogen level regulation
2. Genetic markers for testosterone and estrogen level regulation identified
3. Maturitas publishes clinical guide on low-dose vaginal estrogens for vaginal atrophy
4. Estrogen helps keep joint pain at bay after hysterectomy
5. Estrogen plus progestin use linked with increased breast cancer incidence and mortality
6. Estrogen Level in Pregnancy May Affect Breast Cancer Risk in Daughters
7. Estrogen fuels autoimmune liver damage
8. NuvaRing Lawsuits Move Forward, as Federal Judge Rules that Plaintiffs’ Experts May Testify on “Bursts” of Estrogen Allegedly Delivered by NuvaRing, Wright & Schulte LLC
9. Exercise-related changes in estrogen metabolism may lower breast cancer risk
10. Estrogen Levels Tied to Risk for Sudden Cardiac Death in Study
11. New Stool Test Might Aid in Early Detection of Colon Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Role of estrogen in colon cancer prevention, treatment studied at UH
(Date:2/22/2017)... ... February 22, 2017 , ... ... advanced data analytics to accurately understand each Medicare Advantage member’s risk, identify ... given population. This new solution helps transform the HCC Risk Adjustment process ...
(Date:2/22/2017)... ... 22, 2017 , ... Doctors on Liens is continuing its steady expansion of ... Rauchman, practicing at North Valley Eye Medical Group in Mission Hills . Eye ... other personal injury cases. These injuries have a major impact on the quality ...
(Date:2/22/2017)... , ... February 22, 2017 , ... Using the power ... utilizing a simple online checklist. Over a period of just 24 months, thousands of ... of an online checklist called T.A.D. , “The internet is not getting quieter. In ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... Quality Insights to help small practices in Delaware, New Jersey, Pennsylvania and West ... the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). , This ...
(Date:2/22/2017)... ... February 22, 2017 , ... A product of digesting a micronutrient found in ... benefit from eating soy foods, while others do not, a University of Pittsburgh Graduate ... produce equol—a substance made by some types of “good” gut bacteria when they metabolize ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... Mass. , Feb. 22, 2017 Merrimack Pharmaceuticals, ... company will host its Fourth Quarter 2016 investor conference call ... 1. The call will cover an update ... fourth quarter and full year 2016 financial results. A press ... will be issued the morning of Wednesday, March 1. Investors ...
(Date:2/22/2017)... NEW YORK , Feb. 22, 2017 ... motor neurone disease partnering deals and agreements entered into ... full report: http://www.reportlinker.com/p03605682-summary/view-report.html Description The Global ... report provides understanding and access to partnering deals and ... - Trends in partnering deals - ...
(Date:2/22/2017)... 22, 2017 According to a new market ... SIMS, CUSCO), Application (Laparoscopy, Colposcopy, Hysteroscopy, D&C, Ablation, Biopsy), & End ... published by MarketsandMarkets, the global market is expected to reach USD ... a CAGR of 7.1% during the forecast period. ... ...
Breaking Medicine Technology: